Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Palliative Care Builds Bridges in Oncology Practice

July 6th 2020

Toby Campbell, MD, MSCI, discusses the nuances of palliative care in oncology.

ASCO 2020 Delivers Growing Insights on Supportive Care, Genetic Testing, and Symptom Management

June 30th 2020

Dawn L. Hershman, MD, MS, spotlights important data pertaining to cancer care delivery, prevention, symptom management, and survivorship that were presented at the 2020 ASCO Virtual Scientific Program.

Evidence Supports Value of Physical Activity in Patients With Cancer

June 25th 2020

Baseline physical activity and physical function prior to a cancer diagnosis or treatment affects survival, with evidence spanning across solid tumor types and hematologic malignancies.

FDA Launches Pilot Website Housing Publicly Available PRO Data From Cancer Trials

June 24th 2020

The FDA has launched a new initiative called Project Patient Voice, which is a website that will serve as a source of publicly available information regarding patient-reported symptoms from cancer trials examining marketed treatments.

FDA Approves Burosumab-twza for Tumor-Induced Osteomalacia

June 22nd 2020

The FDA has approved burosumab-twza (Crysvita) injection for the treatment of patients aged 2 and older with tumor-induced osteomalacia, which is described as the development of tumors that cause weakened and softened bones.

Integrating Nutrition Into the Continuum of Cancer Care

June 18th 2020

In our exclusive interview, Dr. Hegazi, shed light on nutrition-related issues among patients with cancer, early intervention strategies for patients who experience loss of muscle mass and function, and the use of specialized nutrients to prevent muscle degradation.

Plinabulin/Pegfilgrastim Combo Shows Efficacy in Prevention of Severe Neutropenia

June 15th 2020

The combination of plinabulin and pegfilgrastim showed a significant enhancement in the rate of grade 4 neutropenia prevention compared with pegfilgrastim alone in patients undergoing chemotherapy, meeting the primary end point of a prespecified interim analysis of the phase 3 PROTECTIVE-2 trial.

Closing Thoughts on Metastatic Breast Cancers

April 22nd 2020

Assessing the Value of Personalized Treatment in mBC

April 22nd 2020

Considerations for NGS Testing in mTNBC

April 22nd 2020

Treatment Options in Metastatic TNBC

April 22nd 2020

Role of PARP Inhibition and I/O Therapy in TNBC

April 22nd 2020

IMpassion130 Trial Data on PD-L1+ Tumors in TNBC

April 22nd 2020

Sequencing of Therapy in R/R HER2+ mBC

April 22nd 2020

SOPHIA Trial in R/R HER2+ mBC

April 22nd 2020

HER2CLIMB and NALA Trials: R/R HER2+ mBC

April 22nd 2020

Evolving Treatment Landscape of R/R HER2+ mBC

April 22nd 2020

Payer Coverage of IV Versus Oral Therapy in mBC

April 22nd 2020

Compliance and Adherence to Therapy in mBC

April 22nd 2020

Advantages of Oral Taxanes in mBC

April 22nd 2020